Note the timeframe
$Xilio Therapeutics (XLO.US)$ Xilio Therapeutics Inc - Plan to Report Clinical Data for Xtx101 and Xtx301, a Tumor-Activated Il-12, in Q4 of 2024
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
